BioAmp Diagnostics
PrivateLast Round
Grant
Jan 15, 2023
Total Funding Raised
$1.58M
Company Overview
BioAmp Diagnostics operates in Healthcare & Life Sciences and is based in San Carlos, California. Its latest recorded funding round was a Grant round in January 2023.
BioAmp Diagnostics is a biotechnology company that develops rapid, precision diagnostic tests designed to counteract antibiotic resistance by enabling medical providers to identify appropriate antibiotic treatments for bacterial infections.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BioAmp Diagnostics Comparables
Compare BioAmp Diagnostics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Astek Diagnostics | 85% | |
| FluoretiQ | 85% | |
| BacterioScan, Inc. | 82% |
For institutional investors. Book with your work email.
BioAmp Diagnostics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jan 15, 2023 | ||||
| Accelerator | Oct 7, 2022 | ||||
| Grant | May 1, 2020 | ||||
| Grant | Feb 1, 2020 | ||||
| Accelerator | Apr 23, 2019 | ||||
Accelerator | Jun 14, 2017 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
BioAmp Diagnostics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute of Allergy and Infectious Diseases | Grant |
| Blue Bear Ventures | Accelerator |
| America's Seed Fund | Grant |
| CITRIS Foundry | Accelerator |
| Illumina Accelerator | Accelerator |
| National Science Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 15, 2023
$1M grant from the National Science Foundation.
- May 1, 2020
$225K grant from the National Science Foundation.
For institutional investors. Book with your work email.
BioAmp Diagnostics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about BioAmp Diagnostics's valuation, stock price, and market status.
Is BioAmp Diagnostics a public or private company?
BioAmp Diagnostics is a private company.
What is the current stock price of BioAmp Diagnostics?
BioAmp Diagnostics is a private company, so its shares have no public market price. Caplight tracks BioAmp Diagnostics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is BioAmp Diagnostics worth (valuation)?
Valuation information for BioAmp Diagnostics is not publicly available.
Can I buy BioAmp Diagnostics stock?
BioAmp Diagnostics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was BioAmp Diagnostics's last funding round?
BioAmp Diagnostics's most recent funding round was Grant on January 15, 2023.
Who are the main investors in BioAmp Diagnostics?
Key investors in BioAmp Diagnostics include CITRIS Foundry, National Science Foundation.
Will BioAmp Diagnostics IPO soon?
No public IPO plans have been announced for BioAmp Diagnostics.
How can I track BioAmp Diagnostics secondary market activity?
Caplight tracks bids, offers, and trades in BioAmp Diagnostics's shares on secondary markets.